Objective The relative risk of SARS–CoV‐2 infection and COVID‐19 disease severity among
people with rheumatic and musculoskeletal diseases (RMDs) compared to those without …

Objectives Perform a systematic literature review (SLR) on risk and prognosis of SARS-CoV-
2 infection and vaccination against SARS-CoV-2 in patients with rheumatic and …

In view of the COVID-19 pandemic, there is an unmet clinical need for the guidelines on
vaccination of patients with autoimmune inflammatory rheumatic diseases (AIIRD). This …

Background Accumulating evidence suggests a beneficial effective of tumour necrosis factor‐
alpha (TNF‐α) inhibitors on the outcomes of COVID‐19 disease, which, however is not …

Background Our objective is to describe the presentation and complications, including
relapses, of coronavirus disease 2019 (COVID-19) in patients under anti-CD20 treatments …

Objectives The emergence of strains of SARS-CoV-2 exhibiting increase viral fitness and
immune escape potential, such as the Delta variant (B. 1.617. 2), raises concerns in …

Immunocompromised individuals and particularly those with hematologic malignancies are
at increased risk for SARS-CoV-2-associated morbidity and mortality due to immunologic …

Objective The risk of COVID‐19 infection is increased in patients with systemic lupus
erythematosus (SLE) versus those without SLE. Some immunosuppressive medications …

Treatment with rituximab (RTX) blunts SARS-CoV-2 vaccination-induced humoral response.
We sought to identify predictors of a positive immunogenic response to the BNT162b2 …

The clinical evolution of patients infected with the Severe Acute Respiratory Coronavirus
type 2 (SARS-CoV-2) depends on the complex interplay between viral and host factors. The …